Merck MRK Balance Sheet

Income Statement

Quarter End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	107.1B	107.08B	109.16B	107.8B	104.47B	106.73B	106.68B	105.85B
Total Current Assets	32.12B	33.56B	35.72B	33.4B	29.98B	31.95B	32.17B	31.45B
Cash and Equivalents	9.68B	11.15B	12.69B	9.71B	5.66B	8.61B	6.84B	5.58B
Total Non-Current Assets	95.04B	93.94B	94.86B	96.15B	96.72B	97.3B	97.56B	97.45B
Total Liabilities	63.78B	62.56B	63.1B	60.89B	65.73B	65.43B	69.04B	65.43B
Total Current Liabilities	23.17B	23B	24.24B	23.13B	23.39B	23.09B	25.69B	25.1B
Total Non-Current Liabilities	69.29B	68.04B	67.61B	65.83B	76.41B	76.31B	77.03B	71.47B
Common Equity	1.79B	1.79B	1.79B	1.79B	1.79B	1.79B	1.79B	1.79B
Retained Earnings	58.44B	59.93B	61.08B	62.04B	54.2B	57.08B	53.9B	56.7B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	95.38B	87.87B	82.64B	84.4B	91.59B	105.69B	109.16B	106.68B
Total Current Assets	30.61B	24.77B	25.88B	27.48B	27.76B	30.27B	35.72B	32.17B
Cash and Equivalents	6.52B	6.09B	7.97B	9.68B	8.06B	8.1B	12.69B	6.84B
Total Non-Current Assets	40.31B	34.57B	26.88B	26B	25.4B	38.26B	46.06B	37.64B
Total Liabilities	55.07B	53.3B	55.76B	58.4B	66.18B	67.44B	63.1B	69.04B
Total Current Liabilities	17.2B	18.61B	22.21B	22.22B	27.33B	23.87B	24.24B	25.69B
Total Non-Current Liabilities	62.14B	56.04B	53.36B	58.91B	64.22B	74.26B	67.61B	77.03B
Total Equity	40.31B	34.57B	26.88B	26B	25.4B	38.26B	46.06B	37.64B
Common Equity	1.79B	1.79B	1.79B	1.79B	1.79B	1.79B	1.79B	1.79B
Retained Earnings	44.13B	41.35B	42.58B	46.6B	47.36B	53.7B	61.08B	53.9B